4.6 Review

Tubular Cell Glucose Metabolism Shift During Acute and Chronic Injuries

Journal

FRONTIERS IN MEDICINE
Volume 8, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2021.742072

Keywords

glycolysis; gluconeogenesis; metabolic shift; acute kidney injury; chronic kidney disease

Funding

  1. Swiss National Science Foundation [SNSF PP00P3-187186/1, SNSF 323530_191224]
  2. Carlos et Elsie de Reuter Founding
  3. Jules Thorn Foundation
  4. NCCR Kidney.ch

Ask authors/readers for more resources

Acute and chronic kidney disease result in significant healthcare costs worldwide. Kidney metabolism undergoes profound changes during injury, potentially affecting fibrosis progression. Glucose metabolism may play a crucial role in both acute and chronic phases of renal disease.
Acute and chronic kidney disease are responsible for large healthcare costs worldwide. During injury, kidney metabolism undergoes profound modifications in order to adapt to oxygen and nutrient shortage. Several studies highlighted recently the importance of these metabolic adaptations in acute as well as in chronic phases of renal disease, with a potential deleterious effect on fibrosis progression. Until recently, glucose metabolism in the kidney has been poorly studied, even though the kidney has the capacity to use and produce glucose, depending on the segment of the nephron. During physiology, renal proximal tubular cells use the beta-oxidation of fatty acid to generate large amounts of energy, and can also produce glucose through gluconeogenesis. In acute kidney injury, proximal tubular cells metabolism undergo a metabolic shift, shifting away from beta-oxidation of fatty acids and gluconeogenesis toward glycolysis. In chronic kidney disease, the loss of fatty acid oxidation is also well-described, and data about glucose metabolism are emerging. We here review the modifications of proximal tubular cells glucose metabolism during acute and chronic kidney disease and their potential consequences, as well as the potential therapeutic implications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Transplantation

Renal gluconeogenesis: an underestimated role of the kidney in systemic glucose metabolism

David Legouis, Anna Faivre, Pietro E. Cippa, Sophie de Seigneux

Summary: Gluconeogenesis is a metabolic pathway that synthesizes glucose from non-hexose precursors and plays a critical role in glucose homeostasis. The kidney contributes significantly to systemic gluconeogenesis, with lactate being the main substrate. Factors such as insulin, cellular glucose levels, acidosis, and stress hormones regulate renal gluconeogenesis. Impaired renal gluconeogenesis in acute and chronic kidney disease can lead to systemic metabolic disturbances. This review highlights the importance of kidney gluconeogenesis and its implications in kidney disease.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Editorial Material Transplantation

Haemoglobin as a marker of fibrosis in early diabetic kidney disease

Anna Faivre, Sophie de Seigneux

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Article Urology & Nephrology

Diffusion-magnetic resonance imaging predicts decline of kidney function in chronic kidney disease and in patients with a kidney allograft

Lena Berchtold, Lindsey A. Crowe, Christophe Combescure, Miklos Kassai, Ibtisam Aslam, David Legouis, Solange Moll, Pierre-Yves Martin, Sophie de Seigneux, Jean-Paul Vallee

Summary: Delta ADC measured with diffusion-weighted magnetic resonance imaging can predict kidney function decline and dialysis initiation in patients with native kidney disease or kidney allograft, independent of baseline kidney function and proteinuria.

KIDNEY INTERNATIONAL (2022)

Article Biochemistry & Molecular Biology

Estimated Renal Metabolomics at Reperfusion Predicts One-Year Kidney Graft Function

Thomas Verissimo, Anna Faivre, Sebastian Sgardello, Maarten Naesens, Sophie de Seigneux, Gilles Criton, David Legouis

Summary: Renal transplantation is the gold-standard procedure for end-stage renal disease patients, providing improved quality of life and life expectancy. By analyzing the renal metabolome after transplantation, it is possible to predict renal function one year after allograft kidney recipients, aiding in patient management optimization.

METABOLITES (2022)

Article Urology & Nephrology

Decreased Renal Gluconeogenesis Is a Hallmark of Chronic Kidney Disease

Thomas Verissimo, Anna Faivre, Anna Rinaldi, Maja Lindenmeyer, Vasiliki Delitsikou, Christelle Veyrat-Durebex, Carolyn Heckenmeyer, Marylise Fernandez, Lena Berchtold, Delal Dalga, Clemens Cohen, Maarten Naesens, Sven-Erik Ricksten, Pierre-Yves Martin, Jerome Pugin, Franck Merlier, Karsten Haupt, Joseph M. Rutkowski, Solange Moll, Pietro E. Cippa, David Legouis, Sophie de Seigneux

Summary: Chronic kidney disease affects the renal gluconeogenic pathway, leading to systemic metabolic changes and a worse renal prognosis.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Transplantation

Evolution of hypoxia and hypoxia-inducible factor asparaginyl hydroxylase regulation in chronic kidney disease

Anna Faivre, Romain Dissard, Willy Kuo, Thomas Verissimo, David Legouis, Gregoire Arnoux, Carolyn Heckenmeyer, Marylise Fernandez, Matthieu Tihy, Renuga D. Rajaram, Vasiliki Delitsikou, Ngoc An Le, Bernhard Spingler, Bert Mueller, Georg Shulz, Maja Lindenmeyer, Clemens Cohen, Joseph M. Rutkowski, Solange Moll, Carsten C. Scholz, Vartan Kurtcuoglu, Sophie de Seigneux

Summary: In this study, it was found that early stages of chronic kidney disease (CKD) are not characterized by hypoxia or hypoxia inducible factor (HIF) activation. Late stages of CKD showed some areas of hypoxia, but they did not colocalize with fibrosis. The HIF pathway was downregulated and FIH expression was increased in CKD. Modulating FIH activity improved glomerular filtration rate and reduced fibrosis in CKD.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Review Urology & Nephrology

Gluconeogenesis in the kidney: in health and in chronic kidney disease

Delal Dalga, Thomas Verissimo, Sophie de Seigneux

Summary: Chronic kidney disease (CKD) is a global health issue with increasing prevalence. Understanding the alterations in metabolism during CKD, particularly in glucose production through gluconeogenesis, is important for developing new therapeutic targets. This review focuses on the metabolic changes in proximal tubular cells during CKD, including the switch from fatty acid oxidation to glycolysis and the loss of tubular gluconeogenesis. The consequences of these metabolic modifications on kidney disease, both locally and systemically, will be discussed. In addition, potential therapeutic interventions will be considered.

CLINICAL KIDNEY JOURNAL (2023)

Article Physiology

PCK1 is a key regulator of metabolic and mitochondrial functions in renal tubular cells

Thomas Verissimo, Delal Dalga, Gregoire Arnoux, Imene Sakhi, Anna Faivre, Hannah Auwerx, Soline Bourgeois, Deborah Paolucci, Quentin Gex, Joseph M. Rutkowski, David Legouis, Carsten A. Wagner, Andrew M. Hall, Sophie de Seigneux

Summary: Phosphoenolpyruvate carboxykinase 1 (PCK1) plays an important role in maintaining normal tubular physiology, lactate, and glucose homeostasis in the kidney. It regulates acid-base balance and ammoniagenesis. Downregulation of PCK1 during renal injury impairs renal function, making it a potential therapeutic target in renal disease.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2023)

Meeting Abstract Medicine, General & Internal

The role of hypoxia-inducible factor asparaginyl hydroxylase (FIH) in chronic kidney disease

Anna Faivre, Romain Dissard, Willy Kuo, Thomas Verissimo, David Legouis, Gregoire Arnoux, Ngoc An Le, Bernhard Spingler, Bert Mueller, Georg Schulz, Maja Lindenmeyer, Clemens Cohen, Joseph M. Rutkowski, Carsten Scholz, Vartan Kurtcuoglu, Sophie De Seigneux

SWISS MEDICAL WEEKLY (2022)

Meeting Abstract Medicine, General & Internal

A transfer learning framework for single cell transcriptomics reveals the role of altered proximal tubule cell states in kidney disease

Daniele Malpetti, Anna Rinaldi, David Legouis, Gregoire Arnoux, Thomas Verissimo, Anna Faivre, Francesca Mangilil, Andrea Rinaldi, Marco Bolis, Maarten Naesens, Lorenzo Ruinelli, Jerome Pugin, Solange Moll', Laura Azzimontil, Sophie De Seigneux, Pietro Cippa

SWISS MEDICAL WEEKLY (2022)

Article Physiology

Kidney-targeted irradiation triggers renal ischemic preconditioning in mice

Badr Khbouz, Francois Lallemand, Arianna Cirillo, Pascal Rowart, David Legouis, Nor Eddine Sounni, Agnes Noel, Pascal De Tullio, Sophie de Seigneux, Francois Jouret

Summary: This study investigates the protective effects and mechanisms of kidney-centered irradiation against renal ischemia-reperfusion injury (I/R). Kidney irradiation increased vascular surface in the renal parenchyma and conferred resistance against renal I/R damage. These findings suggest potential strategies for the treatment of ischemic acute kidney injury.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2022)

No Data Available